Subfoveal Choroidal Thickness after Ranibizumab Therapy for Neovascular Age-related Macular Degeneration: 12-Month Results
Ophthalmology, 05/04/2012Yamazaki T et al.
Subfoveal choroidal thickness decreased after intravitreal injections of ranibizumab in eyes with neovascular age–related macular degeneration. Intravitreal injections of ranibizumab may provide a pharmacologic effect not only on the neovascular lesion but also on the underlying choroid.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.